000			01938 a2200529 4500
005			20250515080540.0
264		0	_c20080619
008			200806s 0 0 eng d
022			_a0344-5704
024	7		_a10.1007/s00280-007-0557-x _2doi
040			_aNLM _beng _cNLM
100	1		_aLu, Jianjun
245	0	0	_aThe preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _cMay 2008
300			_a997-1005 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntibodies, Blocking _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Compounding
650	0	4	_aDrug Delivery Systems
650	0	4	_aEndothelial Cells _xdrug effects
650	0	4	_aFluorescein-5-isothiocyanate
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xchemistry
650	0	4	_aLactic Acid
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMicrospheres
650	0	4	_aNeoplasm Transplantation
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aParticle Size
650	0	4	_aPilot Projects
650	0	4	_aPolyesters
650	0	4	_aPolyglycolic Acid
650	0	4	_aPolylactic Acid-Polyglycolic Acid Copolymer
650	0	4	_aPolymers
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aVascular Endothelial Growth Factor Receptor-2 _ximmunology
700	1		_aJackson, John K
700	1		_aGleave, Martin E
700	1		_aBurt, Helen M
773	0		_tCancer chemotherapy and pharmacology _gvol. 61 _gno. 6 _gp. 997-1005
856	4	0	_uhttps://doi.org/10.1007/s00280-007-0557-x _zAvailable from publisher's website
999			_c17232451 _d17232451